March 03, 2026 — 1 articles reviewed
Today’s feed centers on a single but important theme: the longitudinal relationship between regular cannabis use and anxiety outcomes. New cohort data challenges the popular narrative that cannabis is a reliable long-term solution for anxiety management.
😟 Regular Cannabis Use and Rising Anxiety Risk Over Time
A decade-long cohort study out of McMaster University tracked cannabis use and anxiety outcomes in a Canadian population, finding a dose-dependent association between regular use and increased anxiety symptoms over time. Frequent users were more likely to receive anxiety disorder diagnoses compared to non-users, with the risk amplified in individuals who already carried baseline anxiety vulnerabilities or a family history of anxiety disorders. The proposed mechanism involves dysregulation of the HPA axis and disrupted endocannabinoid signaling in brain regions that govern emotional regulation. This is clinically relevant because many patients self-report short-term relief from cannabis, which can obscure a gradual worsening of their underlying anxiety architecture. The practical takeaway for clinicians is clear: risk stratification matters, and patients with anxiety predispositions deserve transparent counseling about the difference between acute symptom relief and long-term trajectory.
- #72Worrying link between cannabis use and anxiety revealed in new study and the impact … – UNILAD
Short-term relief is real, but it is not the whole story. When we prescribe or counsel around cannabis for anxiety, we owe patients an honest conversation about what a decade of data now tells us about sustained use in vulnerable populations.